1. Home
  2. NATH vs PRLD Comparison

NATH vs PRLD Comparison

Compare NATH & PRLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nathan's Famous Inc.

NATH

Nathan's Famous Inc.

HOLD

Current Price

$98.58

Market Cap

413.9M

ML Signal

HOLD

Logo Prelude Therapeutics Incorporated

PRLD

Prelude Therapeutics Incorporated

HOLD

Current Price

$4.61

Market Cap

391.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NATH
PRLD
Founded
1916
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Restaurants
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
413.9M
391.1M
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
NATH
PRLD
Price
$98.58
$4.61
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$5.67
AVG Volume (30 Days)
18.5K
332.0K
Earning Date
06-09-2026
05-13-2026
Dividend Yield
1.99%
N/A
EPS Growth
N/A
23.21
EPS
4.85
N/A
Revenue
$104,201,000.00
$12,140,000.00
Revenue This Year
N/A
$320.10
Revenue Next Year
N/A
$100.00
P/E Ratio
$20.41
N/A
Revenue Growth
7.81
73.43
52 Week Low
$88.67
$0.75
52 Week High
$113.59
$5.69

Technical Indicators

Market Signals
Indicator
NATH
PRLD
Relative Strength Index (RSI) N/A N/A
Support Level N/A N/A
Resistance Level N/A N/A
Average True Range (ATR) 0.00 0.00
MACD 0.00 0.00
Stochastic Oscillator 0.00 0.00

Price Performance

Historical Comparison
NATH
PRLD

About NATH Nathan's Famous Inc.

Nathan's Famous Inc is a branded licensor, wholesaler and retailer of products marketed under its brand. Its products are currently marketed for sale in thousands of locations, including supermarkets, mass merchandisers and club stores, selected foodservice locations and its company-owned and franchised restaurants throughout the United States and in twenty foreign countries. It considers itself to be in the foodservice industry. It has three segments Branded Product Program, Product Licensing, Restaurant Operations, of which majority of revenue is from Branded Product Program which derives from the sale of hot dog products either directly to foodservice operators or to various foodservice distributors. It generates majority of revenue from United States.

About PRLD Prelude Therapeutics Incorporated

Prelude Therapeutics Incorp is a precision oncology company developing medicines in areas of high unmet need for cancer patients. Its pipeline features selective KAT6A degraders and mutant selective JAK2V617F JH2 inhibitors, new approaches to clinically validated targets with transformative potential for patients. The company is also leveraging its expertise in targeted protein degradation to discover and develop next-generation degrader antibody conjugates (DACs) with novel payloads.

Share on Social Networks: